Skip to content

Checked

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

NCT04752722 on ClinicalTrials.gov

Study listings come from ClinicalTrials.gov, where sponsors register and update their own studies. A listing does not mean a study is safe or effective, and DatenUS does not recommend any study. Talk with your doctor before joining a clinical trial, and use ClinicalTrials.gov for contact details and full eligibility rules.

Status
Recruiting
Phase
Phase 1, Phase 2
Interventional
Planned enrollment
350
Participants, all sites
U.S. sites
50
In 26 states

Study details

Conditions
Superficial Bladder Cancer, Non-muscle Invasive Bladder Cancer With Carcinoma in Situ, Non-muscle Invasive Bladder Cancer
Sponsor
enGene, Inc. (Industry)
Ages
18 years and older
Sex
All
Healthy volunteers
Not accepted
Start
04/22/2021
Primary completion (expected)
04/30/2028
Last updated by sponsor
08/07/2026

Full eligibility rules, contacts and site names: NCT04752722 on ClinicalTrials.gov

Where the study has sites

Cities with at least one listed U.S. site. Some sites may not be enrolling yet.

  • Alabama: Birmingham
  • Arizona: Scottsdale, Tucson
  • Arkansas: Little Rock
  • California: Los Angeles (2), Irvine, La Jolla, San Diego
  • Colorado: Lakewood
  • District of Columbia: Washington D.C.
  • Florida: Jacksonville, Miami
  • Georgia: Atlanta, Augusta
  • Indiana: Greenwood
  • Kansas: Kansas City
  • Maryland: Baltimore, Hanover
  • Massachusetts: Boston
  • Michigan: Detroit, Grand Rapids
  • Minnesota: Minneapolis, Rochester
  • New Jersey: New Brunswick, Voorhees Township
  • New York: Albany, Buffalo, New Haven, New York, Syracuse
  • North Carolina: Chapel Hill, Durham, Raleigh
  • Ohio: Cincinnati, Gahanna, Middleburg Heights
  • Oregon: Portland
  • Pennsylvania: Philadelphia
  • South Carolina: Myrtle Beach
  • Tennessee: Nashville (2)
  • Texas: Houston (3), Austin, Dallas
  • Utah: Salt Lake City
  • Virginia: Charlottesville
  • Wisconsin: Milwaukee

More studies on the same topic

Frequently asked questions

What does recruiting mean?
Recruiting means the study is currently enrolling participants. Not yet recruiting means it has been registered but has not started enrolling. Enrolling by invitation means participants are selected by the study team rather than through open enrollment.
How do I join a clinical trial?
Read the full eligibility criteria and contact information on ClinicalTrials.gov, then talk with your doctor about whether a study may be right for you. The study team decides who can enroll.

Source: ClinicalTrials.gov, National Library of Medicine · Last updated 08/07/2026